TWST - Twist Bioscience Corporation (TWST) Q1 2024 Earnings Call Transcript
2024-02-02 13:11:04 ET
Twist Bioscience Corporation (TWST)
Q1 2024 Earnings Conference Call
February 2, 2024 08:00 AM ET
Company Participants
Angela Bitting - Senior Vice President, Corporate Affairs
Emily Leproust - Chief Executive Officer & Co-Founder
Adam Laponis - Chief Financial Officer
Conference Call Participants
Matt Sykes - Goldman Sachs
Steven Mah - Cowen
Vijay Kumar - Evercore ISI
Luke Sergott - Barclays
Matt Larew - William Blair
Catherine Schulte - Baird
Puneet Souda - Leerink Partners
Sung-Ji Nam - Scotiabank
Rachel Vatnsdal - JPMorgan
Presentation
Operator
Welcome to Twist Bioscience's Fiscal 2024 First Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. Instructions will be given at that time.
I would like to turn the conference over to Angela Bitting, Senior Vice President of Corporate Affairs.
Angela Bitting
Thank you, operator. Good morning, everyone. I'd like to thank all of you for joining us today for Twist Biosciences conference call to review our fiscal 2024 first quarter financial results and business progress. We issued our financial results release this morning, which is available at our website at www.twistbioscience.com .
With me on today's call are Dr. Emily Leproust, CEO and Co-Founder of Twist; and Adam Laponis, CFO of Twist. Emily will begin with a review of our recent progress on Twist businesses. Adam will report on our financial and operational performance. Emily will come back to discuss upcoming milestones and direction. We will then open the call for questions.
We would ask that you limit your questions to only one and then re-queue as a courtesy to others on the call. As a reminder, this call is being recorded. The audio portion will be archived in the Investors section of our website and will be available for two weeks.
During today's presentation, we will make forward-looking statements within the meaning of the US federal securities laws. Forward-looking statements generally relate to future events or future financial or operating performance. Our expectations and beliefs regarding these matters may not materialize and actual results and financial periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
These risks include those set forth in the press release we issued earlier today as well as those partially described in our filings with the Securities and Exchange Commission. Forward-looking statements in this presentation are based on information available to us as of the date hereof and we disclaim any obligation to update any forward-looking statements except as required by law....
Twist Bioscience Corporation (TWST) Q1 2024 Earnings Call Transcript